Showing: 49 results
Jonas Cederhage
Executive Vice President Product Development and Supply Chain & Operations, born 1967. Education and professional experience: M.Sc. in Mechanical Engineering, Lund University. Previous experience of various positions in Alfa Laval, inter alia, VP Operations – Operations Development Manager, Supply Chain Director of Cardo Flow Solutions and Flügger A/S, VP Supply Chain of ArjoHuntleigh AB and COO Manufacturing Capital Equipment in Getinge Group.
Year-end report for 2020
Year-end report for 2020 Arjo's year-end report for 2020 will be published on February 3, 2021.
year end 2021
Year-end report for 2021 Arjo's year-end report for 2021 will be published on February 3, 2022.
Eva Elmstedt
and member of the management of Nokia Networks and Nokia Siemens Networks, and leading roles in Ericsson, the operator 3 and Semcon.
Annual Report 2019
Annual Report 2019 Arjo's Annual Report and Sustainability Report for 2019 was published on April 3. It is available for download under Reports & Presentations, and the digital version is available via the link below: https://arjo.inpublix.com/2019/en
Design for care of plus size residents
As people are growing larger, there is a need to ensure plus size residents can receive safe, dignified and respectful care, without putting caregivers at risk.
Understanding the needs of the resident
In elderly care facilities, different people with different preferences, backgrounds and abilities live together and are taken care of. It is their home – often their last home.
In the resident bathroom
Allocating enough space for the use of optimal equipment allows for a safe and comfortable assisted routines that could be performed by a single caregiver.
Corridors, elevators, storage and free passage
Sufficient space is required in all areas in the care environment to provide the best opportunities for efficient care operations.
Clinical evidence on Early Mobility in the ICU
Clinical evidence survey on Early Mobility in the ICU | Arjo Early mobilisation has been shown to be both safe and feasible for patients admitted to critical care. Download our clinical evidence summary.